Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johny Nicolas

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
European Heart Journal|June 1, 2026
Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impactJohny Nicolas, Angelo Oliva, Rebecca Cohen, et al.
The American Journal of Cardiology|October 1, 2020
Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting StentsAnastasios Roumeliotis, Bimmer Claessen, George Dangas, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 25, 2021
Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromesAnastasios Roumeliotis, Bimmer E Claessen, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|February 11, 2026
Major Bleeding Risk Assessment With Atrial Fibrillation Post-TAVR: The HARHP Score Results From ENVISAGE-TAVI AFGeorge D Dangas, Martin Unverdorben, Christian Hengstenberg, et al.
International Journal of Cardiology|June 18, 2022
Predictors of antiplatelet cessation in a real-world patient population undergoing non-cardiac surgery after PCIAnoop N Koshy, Davide Cao, Matthew A Levin, et al.
The American Journal of Cardiology|January 21, 2022
Effect of Elevated C-Reactive Protein on Outcomes After Complex Percutaneous Coronary Intervention for Angina PectorisAnton Camaj, Gennaro Giustino, Nikola Kocovic, et al.
International Journal of Cardiology|December 5, 2020
A sex paradox in clinical outcomes following complex percutaneous coronary interventionJohny Nicolas, Bimmer E Claessen, Davide Cao, et al.
Journal of Cardiology|May 15, 2023
Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary interventionDavis Jones, Alessandro Spirito, Samantha Sartori, et al.
European Journal of Preventive Cardiology|March 20, 2025
Prognostic impact of residual inflammatory and triglyceride risk in statin-treated patients with well-controlled LDL cholesterol and atherosclerotic cardiovascular diseaseFrancesca Maria Di Muro, Birgit Vogel, Samantha Sartori, et al.
The Canadian Journal of Cardiology|February 13, 2022
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary InterventionCarlo Andrea Pivato, Davis Jones, Davide Cao, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
European Heart Journal|June 1, 2026
Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impactJohny Nicolas, Angelo Oliva, Rebecca Cohen, et al.
The American Journal of Cardiology|October 1, 2020
Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting StentsAnastasios Roumeliotis, Bimmer Claessen, George Dangas, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 25, 2021
Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromesAnastasios Roumeliotis, Bimmer E Claessen, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|February 11, 2026
Major Bleeding Risk Assessment With Atrial Fibrillation Post-TAVR: The HARHP Score Results From ENVISAGE-TAVI AFGeorge D Dangas, Martin Unverdorben, Christian Hengstenberg, et al.
International Journal of Cardiology|June 18, 2022
Predictors of antiplatelet cessation in a real-world patient population undergoing non-cardiac surgery after PCIAnoop N Koshy, Davide Cao, Matthew A Levin, et al.
The American Journal of Cardiology|January 21, 2022
Effect of Elevated C-Reactive Protein on Outcomes After Complex Percutaneous Coronary Intervention for Angina PectorisAnton Camaj, Gennaro Giustino, Nikola Kocovic, et al.
International Journal of Cardiology|December 5, 2020
A sex paradox in clinical outcomes following complex percutaneous coronary interventionJohny Nicolas, Bimmer E Claessen, Davide Cao, et al.
Journal of Cardiology|May 15, 2023
Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary interventionDavis Jones, Alessandro Spirito, Samantha Sartori, et al.
European Journal of Preventive Cardiology|March 20, 2025
Prognostic impact of residual inflammatory and triglyceride risk in statin-treated patients with well-controlled LDL cholesterol and atherosclerotic cardiovascular diseaseFrancesca Maria Di Muro, Birgit Vogel, Samantha Sartori, et al.
The Canadian Journal of Cardiology|February 13, 2022
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary InterventionCarlo Andrea Pivato, Davis Jones, Davide Cao, et al.
Pageof 10